Home / Recalls / SCA Pharmaceuticals, Inc. / D-0171-2021

D-0171-2021 Class II Terminated

Recalled by SCA Pharmaceuticals, Inc. — Little Rock, AR

Recall Details

Product Type: Drugs
Report Date: December 30, 2020
Initiation Date: December 14, 2020
Termination Date: September 23, 2021
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 654 bags

Product Description

Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dose Container, SCA Pharmaceuticals 8821 Knoedl Ct. Little Rock, AR 72205 Bar Code 70004093232

Reason for Recall

Subpotent drug.

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Lots: 1120025012 BUD: 01/13/2021, 1120025015 BUD: 01/15/2021, 1120025272 BUD: 01/28/2021

Other recalls by SCA Pharmaceuticals, Inc.

D-0405-2024 Class II — HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration = (November 9, 2023)
D-0395-2024 Class II — fentaNYL 2,500 mcg/250 mL in 0.9% Sodium Chloride Injection (Concentration = 10 (November 9, 2023)
D-0401-2024 Class II — fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL I (November 9, 2023)
D-0416-2024 Class II — PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection, (Concentration (November 9, 2023)
D-0396-2024 Class II — fentaNYL 2,500 mcg/50 mL Injection (Concentration = 50 mcg/mL), INTRAVENOUS USE (November 9, 2023)
D-0410-2024 Class II — HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration (November 9, 2023)
D-0414-2024 Class II — PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentrati (November 9, 2023)
D-0417-2024 Class II — PHENYLephrine HCl 5000 mcg/50 mL in 0.9% Sodium Chloride Injection, (Concentrati (November 9, 2023)
D-0400-2024 Class II — fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.04% in 0.9% Sodium Chloride 100 mL In (November 9, 2023)
D-0423-2024 Class II — SUCcinylcholine Chloride 200 mg/10mL Injection (Concentration = 20mg/mL), 10 mL (November 9, 2023)